首页> 美国卫生研究院文献>Disease Markers >Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients
【2h】

Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients

机译:Eg5过表达可预测肝细胞癌患者预后不良

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Eg5 (kinesin spindle protein) plays an essential role in mitosis. Inhibition of Eg5 function results in cell cycle arrest at mitosis, which leads to cell death. To date, Eg5 expression and its prognostic significance have not been studied in hepatocellular carcinoma (HCC). In this study, 26 freshly frozen HCC tissue samples and matched peritumoral tissue samples were evaluated with a one-step qPCR test and immunohistochemical (IHC) analysis was conducted on 156 HCC samples to investigate the relationships among Eg5 expression, clinicopathological factors, and prognosis. Eg5 mRNA and protein expression levels were significantly higher in HCC tissues relative to matched noncancerous tissues (p < 0.05). High Eg5 protein expression was significantly related to liver cirrhosis (p = 0.038) and TNM stage (p = 0.008). Kaplan-Meier survival and Cox regression analyses revealed that Eg5 overexpression (p = 0.001), liver cirrhosis (p = 0.009), and TNM stage (p = 0.025) were independent prognostic factors for overall survival. These findings indicate that Eg5 expression can be used as a biomarker of poor prognosis and as a novel therapeutic target for HCC.
机译:Eg5(驱动蛋白纺锤体蛋白)在有丝分裂中起重要作用。 Eg5功能的抑制导致细胞周期停滞在有丝分裂,从而导致细胞死亡。迄今为止,尚未在肝细胞癌(HCC)中研究Eg5表达及其预后意义。在这项研究中,通过一步qPCR测试评估了26份新鲜冷冻的HCC组织样本和匹配的肿瘤周围组织样本,并对156份HCC样本进行了免疫组织化学(IHC)分析,以研究Eg5表达,临床病理因素与预后之间的关系。与匹配的非癌组织相比,HCC组织中的Eg5 mRNA和蛋白质表达水平显着更高(p <0.05)。高Eg5蛋白表达与肝硬化(p = 0.038)和TNM分期(p = 0.008)显着相关。 Kaplan-Meier生存和Cox回归分析显示,Eg5过表达(p = 0.001),肝硬化(p = 0.009)和TNM分期(p = 0.025)是整体生存的独立预后因素。这些发现表明,Eg5表达可以用作预后不良的生物标志物和作为HCC的新治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号